Search results

Utbildningsplan Kompletterande utbildning för läkare med examen utanför EU/EES och Schweiz Medicinska fakulteten MKULB, Kompletterande utbildning för läkare med examen utanför EU/EES och Schweiz, 90 högskolepoäng Complementary Programme for Physicians with a Medical Degree from outside the EU/EES and Switzerland, 90 credits Program med akademiska förkunskapskrav och med slutlig examen på avancerad

https://www.medicin.lu.se/sites/medicin.lu.se/files/2021-05/MKULB%20KUL%20Utbildningsplan.pdf - 2026-07-07

1 Qualification as corporate activism: How Swedish apparel retailers attach circular fashion qualities to take- back systems Hervé Corvellec Department of Service Studies, Lund University, herve.corvellec@ism.lu.se Herman I. Stål* Umea School of Business and Economics (USBE), Research Institute for Ethics and Sustainability in Business (RiseB), Umea University, herman.stal@umu.se * Author for corr

https://www.ses.lu.se/sites/ses.lu.se/files/corvellec_stal_sjm_author_preprint-archiving-march23_2019.pdf - 2026-07-07

1 Qualification as corporate activism: How Swedish apparel retailers attach circular fashion qualities to take- back systems Hervé Corvellec Department of Service Studies, Lund University, herve.corvellec@ism.lu.se Herman I. Stål* Umea School of Business and Economics (USBE), Research Institute for Ethics and Sustainability in Business (RiseB), Umea University, herman.stal@umu.se * Author for corr

https://www.ses.lu.se/sites/ses.lu.se/files/corvellec_stal_sjm_author_preprint-archiving.pdf - 2026-07-07

Background and purpose As much as one-third of all total hip arthroplasties in patients younger than 60 years may be a consequence of developmental dysplasia of the hip (DDH). Screening and early treatment of neonatal instability of the hip (NIH) reduces the incidence of DDH. We examined the radiographic outcome at 1 year in children undergoing early treatment for NIH. Subjects and methods All chi

Background Children with poor response acute myeloid leukaemia (AML) generally have a very poor outcome. Allogeneic stem cell transplantation (SCT) is often recommended for these children but the benefit is unclear. The aim of this study was to investigate survival for poor response AML patients treated with SCT. Material and Methods Treatment was given according to the NOPHO-AML 2004 protocol. Al

Peripheral T-cell Lymphomas (PTCLs) are rare lymphomas with mostly poor outcome with current treatment. Addition of etoposide to CHOP and up-front consolidation with autologous stem cell transplantation (autoSCT) have shown promising results, but have never been tested in randomized trials. As a complement to retrospective analyses of clinical trials, we aimed at analyzing prognostic factors and o

P>The efficacy and safety of zanolimumab (HuMax-CD4) in patients with relapsed or refractory peripheral T Cell lymphoma (PTCL) was evaluated. Twenty-one adult patients with relapsed or refractory CD4+ PTCL of non-cutaneous type (angioimmunoblastic T cell lymphoma (AITL) n = 9, PTCL-not otherwise specified (NOS) n = 7, anaplastic large cell lymphoma (ALCL) n = 4 and enteropathy type T cell lymphoma

European CH4 and N2O emissions are estimated for 2006 and 2007 using four independent inverse modelling systems, based on different global and regional Eulerian and Lagrangian transport models. This ensemble approach is designed to provide more realistic estimates of the overall uncertainties in the derived emissions, which is particularly important for verifying bottom-up emission inventories. We

In a randomized trial of therapy for FMS-like tyrosine kinase-3 (FLT3) mutant acute myeloid leukemia in first relapse, 224 patients received chemotherapy alone or followed by 80 mg of the FLT3 inhibitor lestaurtinib twice daily. Endpoints included complete remission or complete remission with incomplete platelet recovery (CR/CRp), overall survival, safety, and tolerability. Correlative studies inc

Aims Triple-negative breast cancer (TNBC) is responsible for a disproportionate number of breast cancer (BC) deaths, owing to its intrinsic aggressiveness and a lack of treatment options, especially targeted therapies. Thus, there is an urgent need for the development of better targeted treatments for TNBC. Molecular alteration of AKT-3 was previously reported in oestrogen receptor (ER)-positive B

Aims: The neurotransmitter Neuropeptide Y (NPY) was previously reported as a minor autoantigen in newly diagnosed type 1 diabetes (T1D) patients. The single nucleotide polymorphism at rs16139 (T1128C, L7P) in the NPY gene was associated with an increased risk for the development of type 2 diabetes (T2D). We aimed to develop a radiobinding assay for NPY-L (Leucine) and NPY-P (Proline) autoantibodie

Universitetslektor Kontaktinformation E-post: johan [dot] lindgren [at] mgeo [dot] lu [dot] seOrganisation Miljö- och geovetenskapliga institutionen (MGeo) Hämtställe: 16 WebbplatsJohan Lindgrens profil i Lunds universitets forskningsportalAndra roller Studierektor för forskarutbildningen Miljö- och geovetenskapliga institutionen (MGeo)Molekylär paleobiologi är ett nytt och fascinerande forsknings

https://www.geologi.lu.se/johan-lindgren - 2026-07-07

Reflections: Workshop for Librarians in Harare - The Raoul Wallenberg Institute of Human Rights and Humanitarian Law Skip to content Search for: Search Button Home About Us Who We Are Our History About Raoul Wallenberg Our Theory of Change Staff Opportunities Annual Reports Whistleblower Our work What we do Multi-Disciplinary Research Higher Education Strategic Advice and Analysis Outreach Evaluat

https://rwi.lu.se/news/workshop-for-librarians-in-harare/ - 2026-07-07

PowerPoint-presentation Some reflections on the Global Goals going forward Prof. Emily Boyd, LUCSUS Sustainability Talks Date: 9th of March Time: 8.30-10.00 Venue: Wrangel 1 World-class sustainability Centre - working for over 10 years on some of the most pressing global challenges facing humanity. Aim: to create a better and fairer world now and in the future. About LUCSUS This section of the tal

https://www.sustainability.lu.se/sites/sustainability.lu.se/files/emily_boyd_sustainability_forum_talking_sustainabliity.pptx - 2026-07-07

Brevmall Postadress Lunds universitet, Box 117, 221 00 Lund Besöksadress Medicon Village, hus 301 Telefon 0730 683 698, 046-2220305 E-post sara.naurin@fs.lu.se, johanna.mellgren@fs.lu.se Webbadress www.fs.lu.se Research Serv ices Lund University’s management rules for standard project applications to the Marcus and Amalia Wallenberg Foundation and the Marianne and Marcus Wallenberg Foundation. Not

https://www.staff.lu.se/sites/staff.lu.se/files/2023-10/Management%20rules%20LU%20MAWMMW2024%20-%20standard.pdf - 2026-07-07

Universitetslektor Kontaktinformation E-post: olof [dot] hallonsten [at] fek [dot] lu [dot] seOrganisation Organisation Hämtställe: 10 WebbplatsOlof Hallonstens profil i Lunds universitets forskningsportalAndra roller Forskare Socioekonomiska teknikstudier (SoeTech) Docent Organisation Publikationer Visar av publikationer. Sorterade efter år och sen titel. Filtrera efter typ AllaAntologi (redaktör

https://www.ehl.lu.se/olof-hallonsten - 2026-07-07

2026NeoCircle: pre- and post-operative circulating tumor DNA dynamics predicts survival in neoadjuvant-treated early breast cancer George AM, Chen Y, Gladchuk S, Alcaide M, Dalal H, Meng P, Brueffer C, Saghir H, Kimbung S, Aaltonen K, Oton L, Rushton C, Birkeälv S, Jönsson M, Zackrisson S, Skarping I, Förnvik D, Zander L, Honeth G, Woodhouse S, Howarth K, Borg Å, Ehinger A, Malmberg M, Rydén L, Lo

https://www.scan-b.lu.se/scan-bs-provinsamling/publikationer - 2026-07-07

Forskare Kontaktinformation E-post: meelis [dot] molder [at] mgeo [dot] lu [dot] seOrganisation Miljö- och geovetenskapliga institutionen (MGeo) Hämtställe: 16 WebbplatsMeelis Mölders profil i Lunds universitets forskningsportal Publikationer Visar av publikationer. Sorterade efter år och sen titel. Filtrera efter typ AllaArtikel i vetenskaplig tidskriftKonferensabstractKonferenspaper i proceeding

https://www.nateko.lu.se/sv/meelis-molder - 2026-07-07

Objective. Our aim was to study the risk of a first ischaemic stroke (IS) in patients with atrial fibrillation (AF) treated in primary healthcare. Design. The study population included all adults (n = 11,517), 45 years and older diagnosed with AF, from 75 primary care centres in Sweden between 2001 and 2007. IS was defined as a hospital care event of stroke between 2001 and 2010. Association betwe